The DOI matches its Crossref record; 73 of the 76 references it cites were found in a registry or an index.
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Open accessAbstract
Surface-exposed calreticulin (ecto-CRT) and secreted ATP are crucial damage-associated molecular patterns (DAMPs) for immunogenic apoptosis. Inducers of immunogenic apoptosis rely on an endoplasmic reticulum (ER)-based (reactive oxygen species (ROS)-regulated) pathway for ecto-CRT induction, but the ATP secretion pathway is unknown. We found that after photodynamic therapy (PDT), which generates ROS-mediated ER stress, dying cancer cells undergo immunogenic apoptosis characterized by phenotypic maturation (CD80(high), CD83(high), CD86(high), MHC-II(high)) and functional stimulation (NO(high), IL-10(absent), IL-1β(high)) of dendritic cells as well as induction of a protective antitumour immune response. Intriguingly, early after PDT the cancer cells displayed ecto-CRT and secreted ATP before exhibiting biochemical signatures of apoptosis, through overlapping PERK-orchestrated pathways that require a functional secretory pathway and phosphoinositide 3-kinase (PI3K)-mediated plasma membrane/extracellular trafficking. Interestingly, eIF2α phosphorylation and caspase-8 signalling are dispensable for this ecto-CRT exposure. We also identified LRP1/CD91 as the surface docking site for ecto-CRT and found that depletion of PERK, PI3K p110α and LRP1 but not caspase-8 reduced the immunogenicity of the cancer cells. These results unravel a novel PERK-dependent subroutine for the early and simultaneous emission of two critical DAMPs following ROS-mediated ER stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with a key role of CALR in the immunogenicity of RCD, the RNAi-mediated knockdown of CALR as well as natural defects in the CALR exposure pathway reportedly abolish the ability of dying cancer cells succumbing to anthracyclines to establish protective immunity in mice, whereas the exogenous provision of recombinant CALR confers immunogenic properties to otherwise non-immunogenic variants”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [883]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Self-citationMinotti, G., Menna, P., Salvatorelli, E., Cairo, G., & Gianni, L. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.6 · Cited by 3,868
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Photodynamic therapy and anti-tumour immunity
Castaño, A. P., Mróz, P., & Hamblin, M. R. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1894 · Cited by 2,685
STRING 8--a global view on proteins and their functional interactions in 630 organisms
Jensen, L. J., Kuhn, M., Stark, M., Chaffron, S., Creevey, C. J., Muller, J., Doerks, T., Julien, P., Roth, A. C., Simonovic, M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn760 · Cited by 2,475
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Elliott, M. R., Chekeni, F. B., Trampont, P. C., Lazarowski, E. R., Kadl, A., Walk, S. F., Park, D., Woodson, R. I., Ostankovich, M., Sharma, P., et al. (2009) · Nature · doi:10.1038/nature08296 · Cited by 1,654
Gardai, S. J., McPhillips, K. A., Frasch, S. C., Janssen, W. J., Starefeldt, A., Murphy-Ullrich, J. E., Bratton, D. L., Oldenborg, P.-A., Michalak, M., & Henson, P. M. (2005) · Cell · doi:10.1016/j.cell.2005.08.032 · Cited by 1,473
Flagged first, then by citations
3 of the 76 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Vergely C, Delemasure S, Cottin Y, Rochette L (2007) Preventing the cardiotoxic effects of anthracyclines: from basic concepts to clinical data. Heart Metab 35: 1–7
Cited by
Sorted by citations
Items 201–300 of 800
Jiang, H., Fu, H., Guo, Y., Hu, P., & Shi, J. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121799 · Cited by 98
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Sprooten, J., Laureano, R. S., Vanmeerbeek, I., Govaerts, J., Naulaerts, S., Borràs, D., Kinget, L., Fucikova, J. P., Špíšek, R., Jelinkova, L. P., et al. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2219591 · Cited by 103
Self-citationAnzengruber, F., Avci, P., de Freitas, L. F., & Hamblin, M. R. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c4pp00455h · Cited by 97
Chen, G., Meng, C. L., Lin, K. C., Tuan, H., Yang, H. J., Chen, C.-L., Li, K.-C., Chiang, C., & Hu, Y. C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.11.034 · Cited by 97
Immunogenic cell death inducers for enhanced cancer immunotherapy
Li, Y., Liu, X., Zhang, X., Pan, W., Li, N., & Tang, B. (2021) · Chemical Communications · doi:10.1039/d1cc04604g · Cited by 95
Decoding immunogenic cell death from a dendritic cell perspective
Janssens, S., Rennen, S., & Agostinis, P. (2023) · Immunological Reviews · doi:10.1111/imr.13301 · Cited by 106
Self-citationEmerging role of immunogenic cell death in cancer immunotherapy
Arimoto, K., Miyauchi, S., Liu, M., & Zhang, D. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1390263 · Cited by 103
Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity
Stojanovska, V., Sakkal, S., & Nurgali, K. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00212.2014 · Cited by 96
Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress
Humeau, J., Sauvat, A., Cerrato, G., Xie, W., Loos, F., Iannantuoni, F., Bezu, L., Lévesque, S., Paillet, J., Pol, J. G., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911622 · Cited by 100
Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity
Lamberti, M. J., Nigro, A., Mentucci, F. M., Vittar, N. B. R., Casolaro, V., & Col, J. D. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12030256 · Cited by 99
Bo, M. D., Mattia, E. D., Baboçi, L., Mezzalira, S., Cecchin, E., Assaraf, Y. G., & Toffoli, G. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100702 · Cited by 94
The Achilles’ heel of cancer: targeting tumors via lysosome-induced immunogenic cell death
Taritsa, I. C., Neote, K. S., & Eric, F. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04912-8 · Cited by 98
Addicted to secrete – novel concepts and targets in cancer therapy
Dejeans, N., Manié, S. N., Hetz, C. A., Bard, F., Hupp, T. R., Agostinis, P., Samali, A., & Chevet, É. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.12.003 · Cited by 103
Self-citationZheng, Y., Yin, G., Le, V., Zhang, A., Chen, S., Liang, X., & Liu, J. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.12852 · Cited by 94
Stimulation of dendritic cells by DAMPs in ALA-PDT treated SCC tumor cells
Wang, X., Ji, J., Zhang, H., Fan, Z., Zhang, L., Shi, L., Zhou, F., Chen, W. R., Wang, X., & Wang, X. (2015) · Oncotarget · doi:10.18632/oncotarget.5975 · Cited by 94
Vacchelli, E., Vitale, I., Tartour, É., Eggermont, A. M. M., Sautès‐Fridman, C., Galon, J., Zitvogel, L., Kroemer, G., & Galluzzi, L. (2013) · OncoImmunology · doi:10.4161/onci.25595 · Cited by 95
Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines
Vandenberk, L., Belmans, J., Woensel, M. V., Riva, M., & Gool, S. V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00663 · Cited by 92
Immunogenic Cell Death, DAMPs and Prothymosin α as a Putative Anticancer Immune Response Biomarker
Birmpilis, A. I., Paschalis, A., Mourkakis, A., Christodoulou, P., Kostopoulos, I. V., Antimissari, E., Terzoudi, G. I., Georgakilas, A. G., Armpilia, C., Papageorgis, P., et al. (2022) · Cells · doi:10.3390/cells11091415 · Cited by 91
Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy
Guo, J., Zou, Y., & Huang, L. (2023) · Small Methods · doi:10.1002/smtd.202201307 · Cited by 91
Lin, W., Liu, Y., Wang, J., Zhao, Z., Lǚ, K., He, M., Luoliu, R., He, X., Shen, J., Mao, Z., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202310158 · Cited by 87
Garg, A. D., Elsen, S., Krysko, D. V., Vandenabeele, P., de Witte, P., & Agostinis, P. (2015) · Oncotarget · doi:10.18632/oncotarget.4754 · Cited by 87
Self-citationXiao, L., Zhang, L., Guo, C., Xin, Q., Gu, X., Jiang, C., & Wu, J. (2024) · 癌症：英文版 · doi:10.1002/cac2.12579 · Cited by 87
Targeting endoplasmic reticulum signaling pathways in cancer
Martinon, F. (2012) · Acta oncologica · doi:10.3109/0284186x.2012.689113 · Cited by 75
Chung, C., Lin, C., Chen, C., Hsueh, C., Chang, Y., Wang, C., Chu, P., Tai, S., & Yang, M. (2023) · Advanced Science · doi:10.1002/advs.202204514 · Cited by 90
Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death
Gomes-da-Silva, L. C., Kepp, O., & Kroemer, G. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1841393 · Cited by 88
Oncolytic Viruses as Anticancer Vaccines
Woller, N., rlevik, E. G. ⁄., Ureche, C.-I., Schumacher, A., & hnel, F. K. ⁄. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00188 · Cited by 87
Zheng, R., Zhao, L., Huang, C., Cheng, H. B., Ni, Y., Chen, Z., Cai, H., Zhang, W., Kong, R., & Li, S. (2023) · ACS Nano · doi:10.1021/acsnano.2c11964 · Cited by 85
Nanoplatform-enhanced photodynamic therapy for the induction of immunogenic cell death
Liu, X., Lu, Y., Li, X., Luo, L., & You, J. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.11.058 · Cited by 88
Macrophages regulate the clearance of living cells by calreticulin
Krysko, D. V., Ravichandran, K. S., & Vandenabeele, P. (2018) · Nature Communications · doi:10.1038/s41467-018-06807-9 · Cited by 84
Self-citationXu, C., Yu, Y., Sun, Y., Kong, L., Yang, C., Hu, M. Y., Yang, T., Zhang, J., Hu, Q., & Zhang, Z. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201905213 · Cited by 84
Protein Quality Control in the Endoplasmic Reticulum and Cancer
Moon, H. W., Han, H. G., & Jeon, Y. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103020 · Cited by 86
Type I interferons and endoplasmic reticulum stress in health and disease
(2020) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.10.004 · Cited by 83
Self-citationTargeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy
Liu, Q., Guan, C., Liu, C., Li, H., Wu, J., & Sun, C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113861 · Cited by 86
Jahromi, L. P., Shahbazi, M., Maleki, A., Azadi, A., & Santos, H. A. (2021) · Advanced Science · doi:10.1002/advs.202002499 · Cited by 83
Qi, J., Jin, F., Xu, X., & Du, Y. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s285999 · Cited by 83
Chambers, J. E., & Marciniak, S. J. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00183.2014 · Cited by 83
An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy
Michaud, M., Xie, X., Pedro, J. M. B., Zitvogel, L., White, E., & Kroemer, G. (2014) · OncoImmunology · doi:10.4161/21624011.2014.944047 · Cited by 85
Zuo, T., Fang, T., Zhang, J., Yang, J., Xu, R., Wang, Z., Deng, H., & Shen, Q. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100683 · Cited by 80
Platinum Derivatives Effects on Anticancer Immune Response
Rébé, C., Demontoux, L., Pilot, T., & Ghiringhelli, F. (2019) · Biomolecules · doi:10.3390/biom10010013 · Cited by 85
Wang, X., Qian, J., Yang, Z., Song, Y., Pan, W., Ye, Y., Qin, X., Yan, X., Huang, X., Wang, X., et al. (2023) · Advanced Materials · doi:10.1002/adma.202310964 · Cited by 80
Thiruppathi, J., Vijayan, V., Park, I., Lee, S. E., & Rhee, J. H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1375767 · Cited by 85
Chrétien, A.-S., Roy, A. L., Vey, N., Prébet, T., Blaise, D., Fauriat, C., & Olive, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00122 · Cited by 83
Namas, R. A., Mi, Q., Namas, R. A., Almahmoud, K., Zaaqoq, A. M., Abdul-Malak, O. M., Azhar, N., Day, J., Abboud, A., Zamora, R., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6398 · Cited by 77
Qin, J., Kunda, N. M., Qiao, G., Calata, J. F., Pardiwala, K., Prabhakar, B. S., & Maker, A. V. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.473 · Cited by 80
Photodynamic therapy regulates fate of cancer stem cells through reactive oxygen species
Zhang, Z., Wang, K., Mo, J., Xiong, L., & Wen, Y. (2020) · World Journal of Stem Cells · doi:10.4252/wjsc.v12.i7.562 · Cited by 80
Immunogenic cell death by oncolytic herpes simplex virus type 1 in squamous cell carcinoma cells
Takasu, A., Masui, A., Hamada, M., Imai, T., Iwai, S., & Yura, Y. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.8 · Cited by 79
Jeong, S. D., Jung, B., Ahn, H. M., Lee, D., Ha, J., Noh, I., Yun, C., & Kim, Y. (2021) · Advanced Science · doi:10.1002/advs.202001308 · Cited by 78
DAMP—Induced Allograft and Tumor Rejection: The Circle Is Closing
Land, W. G., Agostinis, P., Gasser, S., Garg, A. D., & Linkermann, A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14012 · Cited by 81
Self-citationGold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models
Humeau, J., Lévesque, S., Kroemer, G., & Pol, J. G. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8885-3_21 · Cited by 84
5-Aza-2′-deoxycytidine potentiates antitumour immune response induced by photodynamic therapy
Wachowska, M., Gabrysiak, M., Muchowicz, A., Bednarek, W., Barankiewicz, J., Rygiel, T. P., Boon, L., Mróz, P., Hamblin, M. R., & Gołąb, J. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.01.017 · Cited by 76
Li, Y., Zhang, X., Wan, X., Liu, X., Pan, W., Li, N., & Tang, B. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202000532 · Cited by 77
Immunogenic Cell Death in Cancer Therapy
Troitskaya, O. S., Novak, D. D., Richter, V. A., & Koval, O. A. (2022) · Acta Naturae · doi:10.32607/actanaturae.11523 · Cited by 78
Danger signals: Chemotherapy enhancers?
Vargas, T. R., & Apétoh, L. (2017) · Immunological Reviews · doi:10.1111/imr.12581 · Cited by 73
Targeting the hallmarks of cancer with therapy-induced endoplasmic reticulum (ER) stress
Garg, A. D., Maes, H., van Vliet, A. R., & Agostinis, P. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975089 · Cited by 72
Self-citationThe application of nanoparticles-based ferroptosis, pyroptosis and autophagy in cancer immunotherapy
Deng, W., Shang, H., Tong, Y., Liu, X., Huang, Q., He, Y. T., Wu, J., Ba, X., Chen, Z., Chen, Y., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02297-8 · Cited by 80
D’Eliseo, D., Manzi, L., & Velotti, F. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0422-2 · Cited by 72
Photodynamic Therapy and Its Role in Combined Modality Anticancer Treatment
Brodin, N. P., Guha, C., & Tomé, W. A. (2014) · Technology in Cancer Research & Treatment · doi:10.1177/1533034614556192 · Cited by 71
Colangelo, T., Polcaro, G., Ziccardi, P., Muccillo, L., Galgani, M., Pucci, B., Milone, M. R., Budillon, A., Santopaolo, M., Mazzoccoli, G., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.29 · Cited by 73
Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
Lee, S., Son, B., Park, G., Kim, H., Kang, H., Jeon, J., Youn, H., & Youn, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092795 · Cited by 72
An ultrasound-driven immune-boosting molecular machine for systemic tumor suppression
Wang, L., Li, G., Cao, L., Dong, Y., Wang, Y., Wang, S., Li, Y., Guo, X., Zhang, Y., Sun, F., et al. (2021) · Science Advances · doi:10.1126/sciadv.abj4796 · Cited by 69
Post, S., Nawijn, M. C., Jonker, M. R., Kliphuis, N. M., van den Berge, M., van Oosterhout, A. J. M., & Heijink, I. H. (2013) · Allergy · doi:10.1111/all.12202 · Cited by 70
Huang, Y., Dong, Y., Zhao, J., Zhang, L., Kong, L., & Lu, J. J. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.128 · Cited by 70
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, J., Abeliovich, H., Acevedo‐Arozena, A., Adachi, H., Adams, C. M., Adams, P. D., Adeli, K., et al. (2016) · Kölner Universitäts PublikationsServer (Universität zu Köln) · doi:10.5167/uzh-131237 · Cited by 69
Self-citationAutophagy Contributes to the Death/Survival Balance in Cancer PhotoDynamic Therapy
Inguscio, V., Panzarini, E., & Dini, L. (2012) · Cells · doi:10.3390/cells1030464 · Cited by 71
Rossi, A., Pakhomova, O. N., Mollica, P. A., Casciola, M., Mangalanathan, U. M., Pakhomov, A. G., & Muratori, C. (2019) · Cancers · doi:10.3390/cancers11122034 · Cited by 68
Jin, F., Liu, D., Xu, X., Ji, J., & Du, Y. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s314506 · Cited by 71
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma
Decraene, B., Yang, Y., Smet, F. D., Garg, A. D., Agostinis, P., & Vleeschouwer, S. D. (2022) · Genes and Immunity · doi:10.1038/s41435-021-00161-5 · Cited by 75
Self-citationWan, J., Ren, L., Li, X., He, S., Fu, Y., Xu, P., Meng, F., Xian, S., Pu, K., & Wang, H. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2210385120 · Cited by 67
Ji, J., Fan, Z., Zhou, F., Wang, X., Shi, L., Zhang, H., Wang, P., Yang, D., Zhang, L., Chen, W. R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3529 · Cited by 69
Zhang, X., Wang, D., Li, Z., Jiao, D., Jin, L., Cong, J., Zheng, X., & Xu, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00331 · Cited by 73
Endoplasmic Reticulum Stress in the Diabetic Kidney, the Good, the Bad and the Ugly
Cunard, R. A. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4040715 · Cited by 66
Activatable supramolecular photosensitizers: advanced design strategies
Yang, M., Li, X., & Yoon, J. (2020) · Materials Chemistry Frontiers · doi:10.1039/d0qm00827c · Cited by 66
Nie, D., Ling, Y., Lv, W., Liu, Q., Deng, S., Shi, J., Yang, J., Yang, Y., Ouyang, S., Huang, Y., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c03696 · Cited by 65
Gomez‐Cadena, A., Urueña, C. P., Prieto, K., Martínez-Usatorre, A., Donda, A., Barreto, A., Romero, P. J., & Susana Fiorentino, G. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.134 · Cited by 66
Uscanga‐Palomeque, A. C., Calvillo‐Rodríguez, K. M., Gómez‐Morales, L., Lardé, E., Denèfle, T., Caballero-Hernández, D. E., Merle‐Béral, H., Susín, S. A., Karoyan, P., Martínez‐Torres, A. C., et al. (2018) · Cancer Science · doi:10.1111/cas.13885 · Cited by 69
Vigueras, G., Marková, L., Novohradský, V., Marco, A., Cutillas, N., Kostrhunová, H., Kašpárková, J., Ruiz, J., & Brabec, V. (2021) · Inorganic Chemistry Frontiers · doi:10.1039/d1qi00856k · Cited by 65
Heiser, R. A., Cao, A., Zeng, W., Ulrich, M. L., Younan, P., Anderson, M. E., Trueblood, E. S., Jonas, M., Thurman, R., Law, C., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0118 · Cited by 75
Calreticulin, a therapeutic target?
Eggleton, P., Bremer, E., Dudek, E., & Michalak, M. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1164695 · Cited by 64
The complex roles of efferocytosis in cancer development, metastasis, and treatment
Tajbakhsh, A., Gheibi hayat, S. M., Movahedpour, A., Savardashtaki, A., Loveless, R., Barreto, G. E., Teng, Y., & Sahebkar, A. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111776 · Cited by 64
Mitoxantrone triggers immunogenic prostate cancer cell death via p53-dependent PERK expression
Li, C., Sun, H., Wei, W., Liu, Q., Zhang, Y., Zhang, Y., Liu, F., Li, C., Li, C., Ying, K., et al. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00544-2 · Cited by 67
Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells
Adkins, I., Sadilkova, L. K., Hradilova, N., Tomala, J., Kovář, M., & Špíšek, R. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1311433 · Cited by 65
Novel porphyrazine-based photodynamic anti-cancer therapy induces immunogenic cell death
Turubanova, V. D., Mishchenko, T. A., Balalaeva, I. V., Efimova, I., Peskova, N. N., Klapshina, L. G., Lermontova, S. A., Bachert, C., Krysko, O., Vedunova, M. V., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86354-4 · Cited by 64
Self-citationImmunogenic Cell Death in Hematological Malignancy Therapy
Liu, Z., Xu, X., Liu, K., Zhang, J., Ding, D., & Fu, R. (2023) · Advanced Science · doi:10.1002/advs.202207475 · Cited by 63
Yasutan, H. C., Ndhlovu, L. C., Lacuesta, T. L., Kubo, T., Leaño, P. S. A., Niki, T., Oguma, S., Morita, K., Chew, G. M., Barbour, J. D., et al. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.10.022 · Cited by 63
Physical Plasma Elicits Immunogenic Cancer Cell Death and Mitochondrial Singlet Oxygen
Bekeschus, S., Mueller, A., Miller, V., Gaipl, U. S., & Weltmann, K. (2017) · IEEE Transactions on Radiation and Plasma Medical Sciences · doi:10.1109/trpms.2017.2766027 · Cited by 65
Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges
Goto, T. (2019) · Vaccines · doi:10.3390/vaccines7030100 · Cited by 64
Immunogenicity of necrotic cell death
Gamrekelashvili, J., Greten, T. F., & Korangy, F. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1741-x · Cited by 63
Nanomaterials for Combinational Radio–Immuno Oncotherapy
Wang, J., Li, Z., Wang, Z., Yu, Y., Li, D., Li, B., & Ding, J. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910676 · Cited by 62
Potential Mechanisms and Effects of Efferocytosis in Atherosclerosis
Wang, L., Li, H., Tang, Y., & Yao, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585285 · Cited by 67
Lighting up the tumor fire with low-dose irradiation
Herrera, F. G., Romero, P. J., & Coukos, G. (2022) · Trends in Immunology · doi:10.1016/j.it.2022.01.006 · Cited by 68
Emerging Roles of P2X Receptors in Cancer
Adinolfi, E., Capece, M., Amoroso, F., Marchi, E. D., & Franceschini, A. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141012172913 · Cited by 62
Moriya, T., Kitagawa, K., Hayakawa, Y., Hemmi, H., Kaisho, T., Ueha, S., Ikebuchi, R., Yasuda, I., Nakanishi, Y., Honda, T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102424 · Cited by 60
Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy
Cruickshank, B. M., Giacomantonio, M., Marcato, P., McFarland, S. A., Pol, J. G., & Gujar, S. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00654 · Cited by 62
Rothammer, A., Sage, E. K., Werner, C., Combs, S. E., & Multhoff, G. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1286-0 · Cited by 64
NIR-II light evokes DNA cross-linking for chemotherapy and immunogenic cell death
Huang, Y. H., Wei, D., Wang, B., Tang, D., Cheng, A., Xiao, S., Yu, Y., & Huang, W. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.02.012 · Cited by 60
Molecular determinants of immunogenic cell death elicited by radiation therapy
Galassi, C., Klapp, V., Yamazaki, T., & Galluzzi, L. (2023) · Immunological Reviews · doi:10.1111/imr.13271 · Cited by 65
Applications and enhancement strategies of ROS-based non-invasive therapies in cancer treatment
Guo, Q., Tang, Y., Wang, S., & Xia, X. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103515 · Cited by 61
Michaud, H., Eliaou, J., Lafont, V., Bonnefoy, N., & Gros, L. (2014) · OncoImmunology · doi:10.4161/21624011.2014.955684 · Cited by 63
Hansen, H. G., Schmidt, J. D., Søltoft, C. L., Ramming, T., Geertz‐Hansen, H. M., Christensen, B., Sørensen, E. S., Juncker, A. S., Appenzeller‐Herzog, C., & Ellgaard, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.405050 · Cited by 60
Garg, A. D., Bose, M., Ahmed, M. I., Bonass, W. A., & Wood, S. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034475 · Cited by 60
Self-citation
Metadata
- Authors
- Garg, A. D., Krysko, D. V., Verfaillie, T., Kaczmarek, A., Ferreira, G. B., Marysael, T., Rubio, N., Firczuk, M., Mathieu, C., Roebroek, A. J. M., Annaert, W., Golab, J., de Witte, P., Vandenabeele, P., & Agostinis, P.
- Affiliations
- KU Leuven (BE)
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Agostinis, Patrizia
- ORCID
- Venue
- The EMBO Journal
- Published
- 2012-01-17
- Volume
- 31
- Issue
- 5
- Pages
- 1062-1079
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC3298003
- OpenAlex
- W1942176190
- Cited by
- 800
- References
- 76
- Citations by year
- 2026: 43 · 2025: 46 · 2024: 50 · 2023: 80 · 2022: 74 · 2021: 74 · 2020: 72 · 2019: 54 · 2018: 53 · 2017: 45 · 2016: 49 · 2015: 53 · 2014: 46 · 2013: 35 · 2012: 25
- FWCI
- 24.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- University of Alberta
- European Commission (200767)
- Fundacja na rzecz Nauki Polskiej
- Fonds De La Recherche Scientifique - FNRS
- Fonds Wetenschappelijk Onderzoek (G.0529.08)
- KU Leuven (GOA/11/009)
- Universiteit Gent (01M00709)
- Servier
- Vlaamse regering (BOF09/01M00709)
- European Regional Development Fund (POIG. 01.01.02-00-008/08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- calreticulin, ATP release, immunogenic cancer cell death, photodynamic therapy, reactive oxygen species, endoplasmic reticulum stress, PERK, phosphatidylinositol 3-kinase, damage-associated molecular patterns, dendritic cell maturation, antitumor immunity, caspase-8, eIF2α phosphorylation, secretory pathway
- MeSH terms
- CD83 Antigen, Adenosine Triphosphate, Histocompatibility Antigens Class II, Cell Line, Dendritic Cells, Endoplasmic Reticulum, Humans, Immunoglobulins, Membrane Glycoproteins, Neoplasms, Antigens, CD, Cell Death, Photosensitizing Agents, Reactive Oxygen Species, B7-1 Antigen, Calreticulin, B7-2 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
